Koch P, Wilhelm D, Wermelskirchen D, Nebel U, Wilffert B, Peters T
Janssen Research Foundation, Neuss, F.R.G.
Eur J Pharmacol. 1988 Dec 13;158(3):183-90. doi: 10.1016/0014-2999(88)90065-9.
The effects of R 56865, nifedipine, verapamil, diltiazem and flunarizine on K+- and NA-induced contractions and K+-induced 45Ca uptake were compared in the isolated rat aorta. The calcium entry blockers concentration dependently inhibited the K+-induced contraction and 45Ca uptake over the same dose-range. R 56865 inhibited the K+-induced 45Ca uptake, but only partly inhibited the K+-induced contraction. The calcium entry blockers caused a slight rightward shift and a depression of the maximum of the concentration-response curve for the NA-induced contraction. In contrast, R 56865 caused a strong, dose-dependent rightward shift and a depression of the maximum, 10(-6) and 10(-5) M being equieffective. The effects of R 56865 and nifedipine were independent of each other. Nevertheless, the NA-induced increase in 45 Ca uptake, a putative model for Ca influx, was attenuated by R 56865. In conclusion, R 56865 is a weak inhibitor of the K+-induced Ca influx but is without effect on the NA-induced Ca influx. The discrepancy between its effects on K+-induced contractions and 45Ca uptake may be explained by an inhibition of the uptake of 45Ca from the cytosol into the 45Ca pool. The interaction between R 56865 and the alpha 1-adrenoceptor-mediated contractions may be explained by an action at a site that is distinct from the NA-binding-site on the alpha 1-adrenoceptor.
在离体大鼠主动脉中比较了R 56865、硝苯地平、维拉帕米、地尔硫䓬和氟桂利嗪对钾离子和钠离子诱导的收缩以及钾离子诱导的45钙摄取的影响。钙通道阻滞剂在相同剂量范围内浓度依赖性地抑制钾离子诱导的收缩和45钙摄取。R 56865抑制钾离子诱导的45钙摄取,但仅部分抑制钾离子诱导的收缩。钙通道阻滞剂使去甲肾上腺素诱导收缩的浓度-反应曲线略微右移并降低其最大值。相比之下,R 56865引起强烈的、剂量依赖性的右移并降低最大值,10(-6)和10(-5)M等效。R 56865和硝苯地平的作用相互独立。然而,R 56865减弱了去甲肾上腺素诱导的45钙摄取增加,这是钙内流的一个假定模型。总之,R 56865是钾离子诱导的钙内流的弱抑制剂,但对去甲肾上腺素诱导的钙内流无作用。其对钾离子诱导的收缩和45钙摄取作用的差异可能是由于抑制了45钙从细胞质进入45钙池的摄取。R 56865与α1-肾上腺素能受体介导的收缩之间的相互作用可能是由于其作用于与α1-肾上腺素能受体上的去甲肾上腺素结合位点不同的位点。